[{"from": "human", "value": "Describe this molecule. [C][C][=C][Branch2][Ring1][#C][C][=C][Branch2][Ring1][=Branch2][C][Branch1][Branch1][C][C][Ring1][Ring1][C@@][Branch1][O][C][=Branch1][C][=O][C][Ring1][=Branch2][=C][Ring1][N][Branch1][C][C][O][C][C][O]"}, {"from": "gpt", "value": "The molecule has been granted \u201cfast track\u201d status by the U.S. Food and Drug Administration (FDA) after demonstrating promise against one of the most deadly cancers.   MGI-114 (Irofulven) is currently being developed by MGI PHARMA, Inc., an emerging oncology-focused pharmaceutical company based in Minneapolis. Phase III clinical trials involving the drug have been underway since early 2001 at sites in the U.S. and Europe."}]